Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Thor

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Folia Medica Cracoviensia|August 16, 2012
Pathophysiology advances in the treatment of pulmonary hypertensionŁukasz Dobrek, Piotr Thor
Archives of Medical Science : AMS|November 26, 2013
Heart rate variability in overactive bladder experimental modelLukasz Dobrek, Piotr Thor
Folia Medica Cracoviensia|February 4, 2016
The non-motor complications in Parkinson's disease - what can we learn from animal models?Magdalena Kurnik, Piotr Thor
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 25, 2010
[Endothelin in cardiovascular diseases pathophysiology]Łukasz Dobrek, Piotr Thor
Acta Poloniae Pharmaceutica|June 9, 2011
Neuroendocrine activation as a target of modern chronic heart failure pharmacotherapyŁukasz Dobrek, Piotr Thor
Postepy Higieny I Medycyny Doswiadczalnej (Online)|June 17, 2011
Glutamate NMDA receptors in pathophysiology and pharmacotherapy of selected nervous system diseasesLukasz Dobrek, Piotr Thor
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|January 14, 2012
[Autonomic nervous system activity estimated by heart rate variability in cyclophosphamide-induced overactive bladder experimental model]Łukasz Dobrek, Piotr Thor
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|June 24, 2010
[Endothelin antagonists and their role in pharmacotherapy]Łukasz Dobrek, Piotr Thor
Folia Medica Cracoviensia|August 23, 2011
[Localization and functions of c-kit positive cells in the urinary tract]Krzysztof Gil, Wiesław Urbanowicz, Piotr Thor
Folia Medica Cracoviensia|May 24, 2014
New insights into salt-sensitive hypertensionAgata Ziomber, Kajetan Juszczak, Piotr Thor
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Folia Medica Cracoviensia|August 16, 2012
Pathophysiology advances in the treatment of pulmonary hypertensionŁukasz Dobrek, Piotr Thor
Archives of Medical Science : AMS|November 26, 2013
Heart rate variability in overactive bladder experimental modelLukasz Dobrek, Piotr Thor
Folia Medica Cracoviensia|February 4, 2016
The non-motor complications in Parkinson's disease - what can we learn from animal models?Magdalena Kurnik, Piotr Thor
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 25, 2010
[Endothelin in cardiovascular diseases pathophysiology]Łukasz Dobrek, Piotr Thor
Acta Poloniae Pharmaceutica|June 9, 2011
Neuroendocrine activation as a target of modern chronic heart failure pharmacotherapyŁukasz Dobrek, Piotr Thor
Postepy Higieny I Medycyny Doswiadczalnej (Online)|June 17, 2011
Glutamate NMDA receptors in pathophysiology and pharmacotherapy of selected nervous system diseasesLukasz Dobrek, Piotr Thor
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|January 14, 2012
[Autonomic nervous system activity estimated by heart rate variability in cyclophosphamide-induced overactive bladder experimental model]Łukasz Dobrek, Piotr Thor
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|June 24, 2010
[Endothelin antagonists and their role in pharmacotherapy]Łukasz Dobrek, Piotr Thor
Folia Medica Cracoviensia|August 23, 2011
[Localization and functions of c-kit positive cells in the urinary tract]Krzysztof Gil, Wiesław Urbanowicz, Piotr Thor
Folia Medica Cracoviensia|May 24, 2014
New insights into salt-sensitive hypertensionAgata Ziomber, Kajetan Juszczak, Piotr Thor
Pageof 5